| 前收市價 | 1.3200 |
| 開市 | 1.3300 |
| 買盤 | 1.2100 x 100 |
| 賣出價 | 1.3500 x 100 |
| 今日波幅 | 1.2500 - 1.3300 |
| 52 週波幅 | 0.8160 - 2.2390 |
| 成交量 | |
| 平均成交量 | 99,533 |
| 市值 | 83.669M |
| Beta 值 (5 年，每月) | 0.55 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.9800 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 8.00 |
Insider Monkey10 Best New Penny Stocks to Buy Now
In this article, we will take a look at the 10 best new penny stocks to buy now. To see more such companies, go directly to 5 Best New Penny Stocks to Buy Now. The US stock market is currently in a see-saw mode as some analysts believe the recession that was dreaded for long […]
BenzingaWhy Are IO Biotech Shares Trading Lower Today
IO Biotech (NASDAQ: IOBT) randomized 225 patients in its global Phase 3 clinical trial for IO102-IO103, in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) in patients with advanced melanoma. IO102-IO103 is an investigational immune-modulating cancer vaccine designed to target immunosuppressive mechanisms. This clinical milestone is significant as the Phase 3 trial protocol calls for an interim analysis of the overall response rate one year after 225 patients have been enroll
